ArticlePharmacoEconomics2026
Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective.
Julia Whitehall et al.PubMed ↗Publisher ↗
No numbers read from the abstract.